\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={Paracetamol May Increase Cardiac Congenital Malformations Risk in Prediabetic Pregnancy Women},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2020 2020-01-15 (revised: 45 Year 2020 15 January 2020)}
\def\TheID{\makeatother }
\def\TheDate{2020 2020-01-15}
\title{Paracetamol May Increase Cardiac Congenital Malformations Risk in Prediabetic Pregnancy Women}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{Dr. Juan Ariel  Jara-Guerrero}

             \affil[1]{  Juan Ariel Jara Guerrero}

\renewcommand\Authands{ and }

\date{\small \em Received: 11 December 2019 Accepted: 31 December 2019 Published: 15 January 2020}

\maketitle


\begin{abstract}
        


Hepatic fat and abdominal adiposity in early pregnancy promotes impaired glucose homeostasis in mid-pregnancy (De Souza, 2016) and paracetamol overuse predisposes to liver fat. Hyperglycemia induces apoptosis in myocardium, and an amount evidence have demonstrated an increased risk of congenital abnormalities with gestational diabetes.Acetaminophen overdose is the most often cause of acute liver injury and obese women are in particular risk, because is able to induce mitochondrial oxidative stress (Rousar, 2012). Acetaminophen (Paracetamol) usual high doses decreased embryonic hepatic antioxidant systems as glutathione, that play a vital role in the detoxification of exogenous and endogenous chemicals (

\end{abstract}


\keywords{}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 
\section[{Paracetamol May Increase Cardiac Congenital Malformations Risk in Prediabetic Pregnancy Women}]{Paracetamol May Increase Cardiac Congenital Malformations Risk in Prediabetic Pregnancy Women}\par
Dr. Juan Ariel Jara-Guerrero\par
Abstract-Hepatic fat and abdominal adiposity in early pregnancy promotes impaired glucose homeostasis in midpregnancy (De \hyperref[b12]{Souza, 2016)} and paracetamol overuse predisposes to liver fat. Hyperglycemia induces apoptosis in myocardium, and an amount evidence have demonstrated an increased risk of congenital abnormalities with gestational diabetes.\par
Acetaminophen overdose is the most often cause of acute liver injury and obese women are in particular risk, because is able to induce mitochondrial oxidative stress  {\ref (Rousar, 2012)}. Acetaminophen (Paracetamol) usual high doses decreased embryonic hepatic antioxidant systems as glutathione, that play a vital role in the detoxification of exogenous and endogenous chemicals \hyperref[b23]{(Mitchell, 1973} {\ref , Ishibashi, 1997}\hyperref[b5]{, Beck, 2001} {\ref , Rousar, 2012, rev)}.\par
The apparent safety of Paracetamol drug, a useful analgesic only (with no anti-inflammatory properties) \hyperref[b28]{(Neto, 2004;} {\ref Hamlyn, 1978} {\ref , Ucheya, 2006}\hyperref[b6]{, Bessems, 2001}) is compromized by its widespread and extensive chronic use, particularly in Peruvian population. Paracetamol though considered safe at a considerable low dose, especially in women, could cause kidney derangement and cardiac malformations during pregnant state  {\ref (Ucheya, 2006)}, if the drug is ingested in the first trimester. Major congenital malformations, including those affecting the cardiovascular system, remain the leading cause of mortality and morbidity in infants of diabetic mothers \hyperref[b33]{(Pinter, 2001)}. Thus, there is an overcome potential maternal acetaminophen (paracetamol) toxicity (Horowitz, 1997). 
\section[{I.}]{I.} 
\section[{Hyperglycemia and Cardiac Malformations}]{Hyperglycemia and Cardiac Malformations}\par
rospective and retrospective cohort studies have demonstrated an increased risk of congenital abnormalities with gestational diabetes. This observation is related to the inclusion of women with unrecognized type 2 diabetes  {\ref (Hoet, 1962} {\ref , López-Quijada, 1974}\hyperref[b27]{, Navarrete, 1970}\hyperref[b1]{, Allen, 2007} {\ref , Pasarella, 2013)}. It is known that glucose-induced malformations in animal models, including retarded growth and abnormal heart development, depend on the developmental stage of hyperglycemic exposure and glucose concentration \hyperref[b38]{(Roest, 2007}\hyperref[b45]{, Scott-Drechsel, 2013)}.\par
Diabetes mellitus in pregnancy is associated with an increased incidence of various congenital anomalies that occur during organogenesis. Pregnancy in itself is diabetogenic as a result of an augmented physiological insulin resistance \hyperref[b62]{(Wu, 1996;} {\ref Jara, 2001)}. Thus, pregestational diabetes is a major risk factor of congenital heart defects (CHD).\par
Animal and human confirmed a role for the diabetic state and elevated insulin resistance in inducing congenital fetal malformations, and free radicals excess have been compromised by week 8 of gestation. In this way, the major congenital malformations associated with non-physiological insulin resistance in pregnancy are caudal regression and renal, cardiac and central nervous system abnormalities  {\ref (Ryan, 1998, rev)}.\par
Pregestational diabetes resulted in CHDs in 58\% of the offspring, including ventricular septal defect (VSD), atrial septal defect (ASD), atrioventricular septal defects (AVSD), transposition of great arteries (TGA), double outlet right ventricle (DORV) and tetralogy of Fallot (TOF). Treatment with N-acetylcysteine (NAC) in drinking water in pre-gestational diabetic mice completely eliminated the incidence of AVSD, TGA, TOF and significantly diminished the incidence of ASD and VSD \hyperref[b25]{(Moazzen, 2014)}. It has been demonstrated that maternal hyperglycemia caused a dilation of lategestation fetal ventricular chambers, a reduction of total ventricular myocardial area, and an increase in transversal ascending thoracic aortic area  {\ref (Gutierrez, 2007)}.\par
Intensive care of the pregnant mother with diabetes has dramatically decreased the incidence of diabetic embryonic malformations and clinical reports seem to link facial malformations to an increased incidence of sacral-caudal malformations in human diabetic pregnancy \hyperref[b14]{(Eriksson, 1985}\hyperref[b32]{, Pinter, 1986)}. Indeed, congenital malformations in experimental diabetes can be prevented by antioxidants, in vivo \hyperref[b48]{(Simán, 1997}\hyperref[b34]{, Reece, 1997}) that replace the glutathione depletion in mother. Improving the embryonic capability to scavenge oxygen radicals, either by increasing superoxide dismutase activity or by supplying a ratelimiting precursor (N-acetylcysteine) for the enhanced synthesis of reduced glutathione, blocks the embryonic dysmorphogenesis \hyperref[b59]{(Wentzel, 1997)}.\par
Hyperglycemia may increase adult heart myocardial apoptosis (Gutierrez, 2009). There has been extensive evidence: maternal hyperglycemia is an inducer of birth defects that include a high incidence of cardiovascular malformations \hyperref[b34]{(Reece, 1997;} {\ref Gutierrez, 2009)}. 
\section[{II. Maternal Diabetes Mellitus may Cause Teratogenesis}]{II. Maternal Diabetes Mellitus may Cause Teratogenesis}\par
Maternal diabetes mellitus is associated with increased teratogenesis risks, which can occur in pregestational type 1 and type 2 diabetes. Cardiac defects and neural tube defects are the most common malformations observed in fetuses of pre-gestational diabetic mothers \hyperref[b9]{(Corrigan, 2009)}. In addition, in nondiabetic populations, there is several reports that support the powerful association between maternal obesity and risk of congenital heart defects, this association was present not only for congenital heart defects as a group, but for numerous individual defects \hyperref[b22]{(Mills, 2010)}.\par
The significant correlation between maternal hyperglycemia in early pregnancy and the risk of fetal abnormalities in pregnant women with diabetes mellitus, particularly type 1 \hyperref[b52]{(Todorova, 2005)} and non-knowntype 2 diabetes mellitus is in line with several reports that demonstrated that fetal abnormalities are strongly associated with higher levels of glycosylated Hemoglobin in the first trimester of pregnancy. \hyperref[b52]{(Todorova, 2005)}, and this elevation in A-1c Hemoglobin has a direct correlation with hepatic glutathione levels \hyperref[b42]{(Sakamaki, 1999)} .\par
In this way, maternal hyperglycemia is thought to be the primary teratogen, causing particularly adverse effects on cardiovascular development. \hyperref[b9]{(Corrigan, 2009)}. Fetal cardiac defects are associated with raised maternal glycosylated hemoglobin levels up to five times more likely in infants of mothers with pre-gestational diabetes compared with those without diabetes: this cardiac defects include transposition of the great arteries, mitral and pulmonary atresia, double outlet of the right ventricle, tetralogy of Fallot, and fetal cardiomyopathy \hyperref[b9]{(Corrigan, 2009)}.\par
Despite improvements in prenatal care, the incidence of congenital malformations in diabetic pregnancies is still 3-4 times higher than in normal pregnancies. These defects could be attributed to alterations of intrauterine environment due to disorder of the maternal metabolism  {\ref (Giavini, 1991)}. Glutathione (GSH), a tripeptide implicated in cellular protection against reactive oxygen species, is involved in diabetesrelated embryotoxicity Interestingly, teratogenicity of maternal serum in diabetic pregnancy is not mediated exclusively by increased concentrations of glucose and ketone bodies as its demonstrated by Wentzel et.al \hyperref[b58]{(Wentzel, 1996}\hyperref[b60]{, Wentzel, 2008)}. Both genetic background and obesity influence the severity of fetal abnormalities in animals \hyperref[b9]{(Corrigan, 2009)}.\par
Previous studies in vivo and in vitro have suggested that the oxidative metabolism of the embryo may have a role in the teratogenicity of diabetic pregnancy. In particular, the production of reactive oxygen species by the embryonic mitochondria has been implicated in the teratological process. The induction of congenital malformations by the diabetic milieu occurs during the early embryonic development \hyperref[b63]{(Yang, 1995)}. Hyperglycemia during organogenesis has a primary deleterious effect on yolk sac function with resultant embryopathy \hyperref[b32]{(Pinter, 1986)}.\par
Diabetes-induced malformations have been often related, both in vivo and in vitro studies, to morphological and physiological alterations of the yolk sac, the principal organ for the passage of nutrients from the mother to the rodent embryo  {\ref (Giabini, 1993)}. The embryos explanted from diabetic mothers showed signs of developmental retardation and 16\% were morphologically abnormal  {\ref (Menegola, 1996)}. In addition, reduction in embryonic GSH could reduce the protection against the oxidative stress condition described in diabetic pathology.\par
Norbert Freinkel suggested that the altered fuel mixture offered to the growing conceptus may be the key to most of the changes in the embryogenesis of diabetic pregnancy. He coined the term fuel-mediated teratogénesis. In vitro  {\ref (Eriksson, 1991)} and in vivo, a high glucose concentration causes embryonic dysmorphogenesis by generation of free oxygen radicals. An enhanced production of such radicals in embryonic tissues is directly related to an increased risk of congenital malformations in occult diabetic pregnancy.\par
In this concept, an abnormal handling of reactive oxygen species (ROS) is involved in diabetesinduced dysmorphogenesis in vivo. Indeed, an increased concentration of lipid peroxides, indicating damage caused by ROS, was found in fetuses of diabetes rats. In addition, embryos of diabetic rats had low concentrations of the antioxidant vitamin E compared to control embryos (Simán, 1997 a, b). On the whole, in vivo and in vitro experiments indicate that hyperglycemia itself is not a major factor in producing diabetic embryopathies (Giavini, 1993), but several depletion of tissues glutathione does it. In this way, antiteratogenic effects of supplementation of Nacetylcysteine in vitro has been demonstrated: Nacetylcysteine limits the teratogenicity of glucose \hyperref[b59]{(Wentzel, 1997} {\ref , Roes, 2007)}.\par
There is a solid experimental, clinical and epidemiological evidence that support that increased glucose levels caused embryonic mal development in both normal and diabetic serum. Moreover, despite normalization of the diabetic state, the serum from the insulin-treated diabetic rats caused more growth retardation than the nondiabetic control serum  {\ref (Wentze, 1996)}.\par
Therefore, the pathogenesis of fetal malformations in diabetic pregnancy is multifactorial. Thus, maintaining metabolites from all nutrient classes at a normal level may be important in preventing adverse fetal outcome  {\ref (Eriksoon, 1993;}\hyperref[b51]{Styrud, 1995)} In the second part of gestation, the rate of heart myocardial apoptosis may increase in adult mice under a hyperglycemic environment \hyperref[b19]{(Frustaci, 2000}\hyperref[b18]{, Fiordaliso, 2001}\hyperref[b8]{, Cai, 2002)}  
\section[{Paracetamol has a Potential Teratogenic Agent}]{Paracetamol has a Potential Teratogenic Agent}\par
Glutathione, severely depleted in in vitro and in vivo models of diabetes \hyperref[b54]{(Trocino, 1995}\hyperref[b25]{, Moazzen, 2014)} is probably, the main causality factor in cardiomyocyte apoptosis (Ghosh, 2005), in addition the hyperglycemia, and both of them potentially occur, even, at usual highdoses of paracetamol.\par
Teratogenic potential of diabetes may consist of two components; one associated with 'direct' teratogens perturbing developmental processes in embryos at a 'critical moment' in organogenesis, and a second component, associated with a direct or indirect influence of the diabetic environment on developmental processes in the preimplantation embryos. Thus, there is a threshold glucose level associated with a clear increase of the number of litters with severely malformed fetuses in diabetics animals \hyperref[b53]{(Torchinsky, 1997)}: maternal hyperglycemia altered morphology of the lategestation fetal mouse heart  {\ref (Gutierrez, 2007)}.\par
Mitochondrial alterations produced by oxidative stress have been described in embryos developing in a diabetic environment. Interestingly, its been demonstrated recently that Paracetamol in normal doses may be able to induce mitochondrial oxidative stress (Rousar, 2012). In this regard, oxygen radicalsscavenging enzymes potentially reduce the embryotoxic effects induced by diabetic conditions  {\ref (Menegola, 1996)}.\par
Acetaminophen overdose is the most often cause of acute liver injury. The toxic mechanism is linked to formation of an active metabolite that reacts with glutathione generating acetaminophen-glutathione conjugate (APAP-SG). This compound has been recognized to be non-toxic generally. Recent studies showed, however, that APAP-SG could possess a toxic effect too (Rousar, 2012), particularly in visceral / abdominal obese women.\par
Liver glutathione stores become depleted with paracetamol (Kaneo, 1994) overdoses -chronic use-so that the liver is unable to deactivate the toxic metabolites. In fact, the paracetamol induced renal damage in pregnant women results from a mechanism similar to that which is responsible for hepatotoxicity \hyperref[b50]{(Sule, 2006)}; this mechanism is probably participate in cardiac malformations in an early pregnant state.\par
In this context, the worldwide use of paracetamol as a household analgesic, including during pregnancy may be dangerous: in fact, fetal tissues (and maternal) can be adversely affected by paracetamol \hyperref[b28]{(Neto, 2004)}, and are potentially dangerous in the presence of chronic abdominal obesity (pathological insulin resistance) (Jara, 2001) where liver and tissues antioxidant glutathione \hyperref[b35]{(Reed, 1984)} is reduced. 
\section[{Prevention: The Exosomes in Pregnancy Cardiac Malformations}]{Prevention: The Exosomes in Pregnancy Cardiac Malformations}\par
Animal models have been used to study the expression patterns of many genes that contribute to structural defects in the heart, although <10\% of these underlie congenital cardiac defects in humans \hyperref[b2]{(Andersen, 2014}\hyperref[b36]{, Richards, 2010} {\ref , Govindsamy, 2018)}. Intrauterine under-or overnutrition alters offspring cardiac structure and function.\par
The expression of cardiac-specific genes is likely altered reflecting impaired cardiac insulin signalling that contributes to cardiac insulin resistance, that often precedes cardiovascular disease (Govindsamy, 2018), this hormonal event explains the fact that congenital malformations occur despite good glycemic control  {\ref (Mill, 1988;}\hyperref[b48]{Simán, 1997)}, thereby confirming a role for reactive oxygen species ROS and inflammatory and oxidant environment \hyperref[b48]{(Simán, 1997)}, or a lack of antioxidant protection enough, as glutathione, Vitamin E and Selenium.\par
Enhancing synthesis of reduced glutathione blocks the embryonic dysmorphogenesis \hyperref[b59]{(Wentzel, 1997)}, but not in cardiac malformations, because fetal heart was found to be hypertrophic \hyperref[b48]{(Simán, 1997)} (resorption rate in fetal organs tended to be decreased with the increased dosage of vitamin E). Then, maternal administration of vitamin E can prevent congenital malformations in mid and late pregnancy, not in the early pregnancy. In comparison, Selenium may offer other additional advantages: its powerful antioxidant properties preserve reduced glutathione because its role in the major intracellular antioxidant enzyme the glutathione peroxidase (Takahashi, 1986). But Peruvian mothers don´t consume diary selenium nor vitamin D.\par
In addition, it is been demonstrated that acute glutathione depletion causes severe hypertension in normal rats \hyperref[b57]{(Vaziri, 2000)}: Since Paracetamol causes physiological reduction of glutathione, we don´t surprise that this drug may increase blood pressure in advanced insulin resistant humans \hyperref[b49]{(Sudano, 2010)}. Therefore, pregnant women must be caution before taking this drug, but never without medical indication.\par
Placental cells can communicate with maternal tissues to regulate their biological function via extracellular vesicles with immune responses: the exosomes  {\ref (Salomon, 2017, rev)}. Acute hyperglycemia in gestation may disturb exosomes signaling , and may promotes severe malformations that occurs during organogenesis -completed by sixth week after conception-and the critical period for malformations is almost over by the time pregnancy becomes clinically apparent. At this time, the placenta releases exosomes into the maternal circulation -Exosomes are specifically package with signaling molecules, including protein, messenger RNA, microRNA, and noncoding RNA-  {\ref (Mitchell, 2015, rev)}, and elevated maternal exosomes in gestational diabetes strikingly increased the risk of congenital heart defect \hyperref[b26]{(Nair, 2018;}\hyperref[b46]{Shi, 2017)}, and these occurs at high amounts even in pregestational maternal diabetes that induces congenital heart defects (Kone?ná, 2019;  {\ref Zhong, 2018, rev)}.\par
Exosomes released from placental cells and adipose cells have been found to be regulated by oxygen tension and glucose concentration, and abdominal obese women release an excess of this extracellular vesicles that stimulate cytokine release from endothelial cells that increase hepatic and systemic inflammation; a lot of these events disturb placental health and fetal organogenesis in the presence of glucose intolerance exacerbate in paracetamol women consumers.\par
In addition ro paracetamol-side-effects at normal doses, a recent investigation has found transcriptomic changes in full-genome human miRNA expression and immune modulating effects and oxidative stress responses to paracetamol even at low doses (Jetten, 2012). Because it is very frequent that organogenesis is completed before women recognize that they are pregnant, the precounseling and strict planning of pregnancy, even in prediabetic women or gestational diabetes, become an urgent need. 
\section[{IV.}]{IV.} 
\section[{Conclusions}]{Conclusions}\par
Glycolysis regulates cardiometabolism behavior during cardiac wall morphogenesis, and any disturb in metabolism pathway may alter ventricular wall morphogenesis and cause congenital cardiac malformations  {\ref (Fukuda, 2019)}. Furthemore, if a reduction of glutathione levels in cells has been found to increase the risks for diseases and poisoning (Honda, 2017), Paracetamol, is potentially dangerous in pregnant women.\par
Pre-gestational maternal diabetes is associated with strong teratogenic effects on the kidney, urinary tract, and heart, and strongly associated with multiple congenital abnormalities. Pre-conception recognition of women at high risk for type 2 diabetes and optimal glycemic control may reduce the risk of congenital anomalies. A healthy diet and regular exercise \hyperref[b29]{(Nielsen, 2005} {\ref , Allen, 2007, rev)} and reduction in paracetamoltoxicity in a subclinical way, may help optimize prepregnancy weight and reduce the risk of congenital anomalies. Paracetamol may increase the risk of cryptorchidism and asthma during childhood as well as preeclampsia, maternal phlebothrombosis and pulmonary embolism \hyperref[b7]{(Burdan, 2012)} as its recently reported.\par
In the presence of established diabetes, It is must be stress the importance of a strict metabolic control, started well before conception, to prevent excess rates of congenital malformation, and the intensive insulin therapy must be considered as an first option in this regard \hyperref[b20]{(Fuhrmann, 1984)}. Sustained hyperglycemia reduced endocardial and myocardial cell proliferation in the outflow tract of heart and lead to congenital heart malformations (Scott-Drechsel, 2013,  {\ref Roest, 2006)}.\par
In diabetic women who is thinking to pregnant, an optimal metabolic control must been established \hyperref[b52]{(Todorova, 2005)}, and the danger of paracetamol use must be informed, even if the fact that most pregnancies are not recognized clinically until ?2 weeks after conception, thus, many pregnant women are unaware of both their diabetes status during early pregnancy and the increased risk of morbidity and mortality that prediabetes or occult diabetes has on their unborn child \hyperref[b39]{(Roman, 2011} {\ref rev, Scott-Drechsel, 2013)}.\par
Acetaminophen (Paracetamol) is one of the most common causes of poisoning worldwide, in particular in the patients with low amount of the hepatic glutathione  {\ref (Burdan, 2012, rev.)}, that is, insulin resistant and diabetic patients.  \begin{figure}[htbp]
\noindent\textbf{1}\includegraphics[]{image-2.png}
\caption{\label{fig_0}Figure 1 Abnormal}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{} \par 
\begin{longtable}{P{0.6714601159260281\textwidth}P{0.0028153463980126964\textwidth}P{0.0004692243996687828\textwidth}P{0.004926856196522219\textwidth}P{0.16493237648357714\textwidth}P{0.0014076731990063482\textwidth}P{0.0028153463980126964\textwidth}P{0.0011730609991719568\textwidth}}
\multicolumn{4}{l}{Stainier DY Metabolic modulation regulates cardiac}\tabcellsep \multicolumn{2}{l}{antioxidant system in the rat embryo during early}\\
\multicolumn{4}{l}{wall morphogenesis in zebrafish. Elife. 2019 Dec 23;}\tabcellsep \multicolumn{2}{l}{organogenesis. Free Radic Biol Med. 1997;}\\
\multicolumn{2}{l}{8. pii: e50161}\tabcellsep \tabcellsep \tabcellsep 22(3):447-54.\\
\multicolumn{4}{l}{24. Giavini E, Broccia ML, Prati M, Domenico Roversi G.}\tabcellsep \multicolumn{2}{l}{35. Jayabalan N, Nair S, Nuzhat Z, Rice GE, Zuñiga FA,}\\
\multicolumn{4}{l}{Diet composition modifies embryotoxic effects}\tabcellsep \multicolumn{2}{l}{Sobrevia L, Leiva A, Sanhueza C, Gutiérrez JA,}\\
\multicolumn{4}{l}{induced by experimental diabetes in rats Biol}\tabcellsep \multicolumn{2}{l}{Lappas M, Freeman DJ, Salomon C Cross Talk}\\
\multicolumn{3}{l}{Neonate. 1991; 59(5):278-86.}\tabcellsep \tabcellsep \multicolumn{2}{l}{between Adipose Tissue and Placenta in Obese and}\\
\multicolumn{4}{l}{25. Giavini E. Diabetes in pregnancy: experimental}\tabcellsep \multicolumn{2}{l}{Gestational Diabetes Mellitus Pregnancies via}\\
\multicolumn{4}{l}{aspects Ann Ist Super Sanita. 1993; 29(1):27-34.}\tabcellsep \multicolumn{2}{l}{Exosomes. Front Endocrinol (Lausanne). 2017 Sep}\\
\multicolumn{4}{l}{26. Ghosh S, Pulinilkunnil T, Yuen G, Kewalramani G,}\tabcellsep 27;8:239\\
\multicolumn{4}{l}{An D, Qi D, Abrahani A, Rodrigues B Cardiomyocyte}\tabcellsep \multicolumn{2}{l}{36. Jetten MJ, Gaj S, Ruiz-Aracama A, de Kok TM, van}\\
\multicolumn{4}{l}{apoptosis induced by short-term diabetes requires}\tabcellsep \multicolumn{2}{l}{Delft JH, Lommen A, van Someren EP, Jennen DG,}\\
\multicolumn{4}{l}{mitochondrial GSH depletion Am J Physiol Heart}\tabcellsep \multicolumn{2}{l}{Claessen SM, Peijnenburg AA, Stierum RH,}\\
\multicolumn{4}{l}{Circ Physiol. 2005 Aug; 289(2):H768-76}\tabcellsep \multicolumn{2}{l}{Kleinjans JC Omics analysis of low dose}\\
\multicolumn{4}{l}{27. Govindsamy A, Naidoo S, Cerf ME Cardiac}\tabcellsep acetaminophen\tabcellsep intake\tabcellsep demonstrates\tabcellsep novel\\
\multicolumn{4}{l}{Development and Transcription Factors: Insulin}\tabcellsep \multicolumn{2}{l}{response pathways in humans Toxicol Appl}\\
\multicolumn{4}{l}{Signalling, Insulin Resistance, and Intrauterine}\tabcellsep \multicolumn{2}{l}{Pharmacol 2012, 259:320-328}\\
\multicolumn{4}{l}{Nutritional Programming of Cardiovascular Disease}\tabcellsep \multicolumn{2}{l}{37. Kaneo Y , Ogawa K, Tanaka T, Fujihara Y, Iguchi S}\\
\multicolumn{6}{l}{J Nutr Metab. 2018 Feb 1;2018:8547976 28. Gutierrez JC, Hrubec TC, Prater MR, Smith BJ, Freeman LE, Holladay SD. Aortic and ventricular dilation and myocardial reduction in gestation day 17 ICR mouse fetuses of diabetic mothers Birth Defects Res A Clin Mol Teratol. 2007 Jun; 79(6):459-64. 29. Gutierrez JC, Prater MR, Smith BJ, Freeman LE, Mallela MK, Holladay SD Late-gestation ventricular myocardial reduction in fetuses of hyperglycemic CD1 mice is associated with increased apoptosis Birth Defects Res B Dev Reprod Toxicol. 2009 Oct; 86(5):409-15 30. Hamlyn AN, Douglas AP, James O. The spectrum of paracetamol (acetaminophen) overdose: clinical and epidemiological studies Postgrad Med J. 1978 Jun; 54(632):400-4. 31. HOET JP, HOET JJ, GOMMERS A, TREMOUROUX-WATTIEZ M. Prediabetes and congenital abnormalities of the heart Rev Fr Gynecol Obstet. 1962 Apr; 57:233-47. 32. Honda Y1, Kessoku T1, Sumida Y2, Kobayashi T1, induced hepatotoxicity dependent Medical Research A protective effect of glutathione-dextran macromolecular conjugates on acetaminophen-Volume XX Issue VII Version I ( D D D D )}\\
\multicolumn{4}{l}{Kato T1, Ogawa Y1, Tomeno W1, Imajo K1, Fujita}\tabcellsep \\
\multicolumn{4}{l}{K1, Yoneda M1, Kataoka K3, Taguri M3, Yamanaka}\tabcellsep \\
\multicolumn{4}{l}{T3, Seko Y4, Tanaka S5, Saito S1, Ono M6, Oeda}\tabcellsep \\
\multicolumn{4}{l}{S7, Eguchi Y7, Aoi W8, Sato K9, Itoh Y4, Nakajima A}\tabcellsep \\
\multicolumn{4}{l}{Efficacy of glutathione for the treatment of}\tabcellsep \\
\multicolumn{4}{l}{nonalcoholic fatty liver disease: an open-label,}\tabcellsep \\
\multicolumn{4}{l}{single-arm, Gastroenterol. 2017 Aug 8; 17(1):96. doi: multicenter, pilot study. BMC 1 , Carbajo-Pescador S 2 , Mauriz JL 2 , González-Gallego J 2 , Soares FA New therapeutic 10.1186/s12876-017-0652-3.}\tabcellsep \\
\multicolumn{4}{l}{approach: 33. Horowitz RS, Dart RS, Jarvie DR, Bearer CF, Gupta diphenyl diselenide reduces}\tabcellsep \\
\multicolumn{4}{l}{mitochondrial dysfunction in acetaminophen-U Placental Transfer of N-Acetylcysteine Following}\tabcellsep \\
\multicolumn{4}{l}{induced acute liver failure PLoS One. 2013 Dec Human Maternal Acetaminophen Toxicity J Toxicol}\tabcellsep \\
\multicolumn{4}{l}{11;8(12):e81961 Clinic Toxicol 1997; 35: 447-451}\tabcellsep \\
\multicolumn{4}{l}{34. Ishibashi M, Akazawa S, Sakamaki H, Matsumoto K,}\tabcellsep \\
\multicolumn{4}{l}{Yamasaki H, Yamaguchi Y, Goto S, Urata Y, Kondo}\tabcellsep \\
\multicolumn{4}{l}{T, Nagataki S. Oxygen-induced embryopathy and}\tabcellsep \\
the\tabcellsep significance\tabcellsep of\tabcellsep glutathione-dependent\tabcellsep \end{longtable} \par
 
\caption{\label{tab_1}}\end{figure}
 			\footnote{© 2020 Global Journals Paracetamol May Increase Cardiac Congenital Malformations Risk in Prediabetic Pregnancy Women} 		 		\backmatter  			  				\begin{bibitemlist}{1}
\bibitem[Reed ()]{b35}\label{b35} 	 		\textit{},  		 			D J Reed 		.  	 	 		\textit{Fariss MW Glutathione Depletion and Oxidant Susceptibility Pharmacol Revi}  		1984. 2 p. .  	 
\bibitem[ Sprague Dawley rats Niger J Physiol Sci (2006)]{b56}\label{b56} 	 		\textit{},  	 	 		\textit{Sprague Dawley rats Niger J Physiol Sci}  		2006 Jun-Dec;21.  (1-2)  p. .  	 
\bibitem[Rou?ar et al. ()]{b40}\label{b40} 	 		‘?ervinková Z Purified acetaminophenglutathione conjugate is able to induce oxidative stress in rat liver mitochondria’.  		 			T Rou?ar 		,  		 			E Nýdlová 		,  		 			P ?esla 		,  		 			P Sta?ková 		,  		 			O Ku?era 		,  		 			P Pa?ík 		.  	 	 		\textit{Physiol Res}  		2012. 61  (2)  p. .  	 	 (Suppl) 
\bibitem[Mitchell et al. ()]{b23}\label{b23} 	 		‘Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione’.  		 			J R Mitchell 		,  		 			D J Jollow 		,  		 			W Z Potter 		,  		 			J R Gillette 		,  		 			B B Brodie 		.  	 	 		\textit{J Pharmacol Exp Ther}  		1973. 187 p. .  	 
\bibitem[Da Silva et al. (2011)]{b10}\label{b10} 	 		\textit{Acute brain damage induced by acetaminophen in mice: effect of diphenyl diselenide on oxidative stress and mitochondrial dysfunction Neurotox Res},  		 			M H Da Silva 		,  		 			E J Da Rosa 		,  		 			N R De Carvalho 		,  		 			F Dobrachinski 		,  		 			J B Da Rocha 		,  		 			J L Mauriz 		,  		 			J González-Gallego 		,  		 			F A Soares 		.  		 \xref{http://dx.doi.org/10.1007/s12640-011-9288-1.Epub}{10.1007/s12640-011-9288-1.Epub}.  		2012 Apr. 2011 Nov 12. 21 p. .  	 
\bibitem[Yang et al. (1995)]{b63}\label{b63} 	 		\textit{Altered mitochondrial morphology of rat embryos in diabetic pregnancy Anat Rec},  		 			X Yang 		,  		 			L A Borg 		,  		 			U J Eriksson 		.  		1995 Feb. 241 p. .  	 
\bibitem[Whitcomb and Block (1994)]{b61}\label{b61} 	 		\textit{Association of acetaminophen hepatotoxicity with fasting and ethanol use JAMA},  		 			D C Whitcomb 		,  		 			G D Block 		.  		1994 Dec 21. 272 p. .  	 
\bibitem[Eriksson and Styrud ()]{b14}\label{b14} 	 		\textit{Congenital malformations in diabetic pregnancy: the clinical relevance of experimental animal studies Acta Paediatr Scand Suppl},  		 			U J Eriksson 		,  		 			J Styrud 		.  		1985. 320 p. .  	 
\bibitem[Simán ()]{b48}\label{b48} 	 		‘Congenital malformations in experimental diabetic pregnancy: aetiology and antioxidative treatment’.  		 			M Simán 		.  	 	 		\textit{Ups J Med Sci}  		1997. 102  (2)  p. .  	 	 (Minireview based on a doctoral thesis) 
\bibitem[Styrud et al. (1995)]{b51}\label{b51} 	 		‘Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats’.  		 			J Styrud 		,  		 			L Thunberg 		,  		 			O Nybacka 		,  		 			U J Eriksson 		.  	 	 		\textit{Pediatr Res}  		1995 Mar. 37  (3)  p. .  	 
\bibitem[Wentzel et al. (2008)]{b60}\label{b60} 	 		‘Decreased cardiac glutathione peroxidase levels and enhanced mandibular apoptosis in malformed embryos of diabetic rats’.  		 			P Wentzel 		,  		 			M Gäreskog 		,  		 			U J Eriksson 		.  	 	 		\textit{Diabetes}  		2008 Dec. 57  (12)  p. .  	 
\bibitem[De Lorgeril et al. ()]{b11}\label{b11} 	 		‘Dietary and Blood Antioxidants in Patients with Chronic Heart Failure: Insigths into the Potential Importance of Selenium in’.  		 			M De Lorgeril 		,  		 			P Salem 		,  		 			M Accominotti 		,  		 			M Cadau 		,  		 			J P Steghens 		,  		 			F Boucher 		,  		 			De Leires 		.  	 	 		\textit{Heart Failure European Journal of Heart Failure}  		2001. 3 p. .  	 
\bibitem[Passarella et al. (2013)]{b30}\label{b30} 	 		\textit{Disorders in glucidic metabolism and congenital heart diseases: detection and prevention Pediatr Cardiol},  		 			G Passarella 		,  		 			G Trifirò 		,  		 			M Gasparetto 		,  		 			G S Moreolo 		,  		 			O Milanesi 		.  		2013 Apr. 34 p. .  	 
\bibitem[Fine et al. (1999)]{b17}\label{b17} 	 		\textit{Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy Diabetes},  		 			E L Fine 		,  		 			M Horal 		,  		 			T I Chang 		,  		 			G Fortin 		,  		 			M R Loeken 		.  		1999 Dec. 48 p. .  	 
\bibitem[Roest et al. (2007)]{b38}\label{b38} 	 		‘Exposure of neural crest cells to elevated glucose leads to congenital heart defects, an effect that can be prevented by Nacetylcysteine’.  		 			P A Roest 		,  		 			L Van Iperen 		,  		 			S Vis 		,  		 			L J Wisse 		,  		 			R E Poelmann 		,  		 			R P Steegers-Theunissen 		,  		 			D G Molin 		,  		 			U J Eriksson 		,  		 			Gittenberger-De Groot 		,  		 			AC 		.  	 	 		\textit{Birth Defects Res A Clin Mol Teratol}  		2007 Mar. 79  (3)  p. .  	 
\bibitem[Corrigan et al. (2009)]{b9}\label{b9} 	 		\textit{Fetal cardiac effects of maternal hyperglycemia during pregnancy Birth Defects Res A Clin Mol Teratol},  		 			N Corrigan 		,  		 			D P Brazil 		,  		 			F Mcauliffe 		.  		2009 Jun. 85 p. .  	 
\bibitem[Adam et al. (2017)]{b0}\label{b0} 	 		‘Fetal-maternal communication via extracellular vesicles -Implications for complications of pregnancies’.  		 			S Adam 		,  		 			O Elfeky 		,  		 			V Kinhal 		,  		 			S Dutta 		,  		 			A Lai 		,  		 			N Jayabalan 		,  		 			Z Nuzhat 		,  		 			C Palma 		,  		 			G E Rice 		,  		 			C Salomon 		,  		 			Review 		.  	 	 		\textit{Placenta}  		2017 Jun. 54 p. .  	 
\bibitem[Richards and Garg (2010)]{b36}\label{b36} 	 		‘Genetics of congenital heart disease’.  		 			A A Richards 		,  		 			V Garg 		.  	 	 		\textit{Curr Cardiol Rev}  		2010 May. 6  (2)  p. .  	 
\bibitem[Souza et al. (2016)]{b12}\label{b12} 	 		‘Hepatic fat and abdominal adiposity in early pregnancy together predict impaired glucose homeostasis in mid-pregnancy’.  		 			De Souza 		,  		 			L R Berger 		,  		 			H Retnakaran 		,  		 			R Vlachou 		,  		 			P A Maguire 		,  		 			J L Nathens 		,  		 			A B Connelly 		,  		 			P W Ray 		,  		 			JG 		.  	 	 		\textit{Nutr Diabetes}  		2016 Sep 19. 6  (9)  p. e229.  	 
\bibitem[Ucheya and Igweh]{b55}\label{b55} 	 		\textit{Histological changes in kidney structure following a long-term administration of paracetamol (acetaminophen) in pregnant},  		 			R E Ucheya 		,  		 			J C Igweh 		.  		 	 
\bibitem[Nair et al. (2018)]{b26}\label{b26} 	 		‘Human placental exosomes in gestational diabetes mellitus carry a specific set of miRNAs associated with skeletal muscle insulin sensitivity’.  		 			S Nair 		,  		 			N Jayabalan 		,  		 			D Guanzon 		,  		 			C Palma 		,  		 			K Scholz-Romero 		,  		 			O Elfeky 		,  		 			F Zuñiga 		,  		 			V Ormazabal 		,  		 			E Diaz 		,  		 			G E Rice 		,  		 			G Duncombe 		,  		 			T Jansson 		,  		 			H D Mcintyre 		,  		 			M Lappas 		,  		 			C Salomon 		.  	 	 		\textit{Clin Sci}  		2018 Nov 29. 132  (22)  p. .  	 	 (d)) 
\bibitem[Fiordaliso et al. (2001)]{b18}\label{b18} 	 		\textit{Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death Diabetes},  		 			F Fiordaliso 		,  		 			A Leri 		,  		 			D Cesselli 		,  		 			F Limana 		,  		 			B Safai 		,  		 			B Nadal-Ginard 		,  		 			P Anversa 		,  		 			J Kajstura 		.  		2001 Oct. 50 p. .  	 
\bibitem[Scott-Drechsel et al. (2013)]{b45}\label{b45} 	 		‘Hyperglycemia slows embryonic growth and suppresses cell cycle via cyclin D1 and p21’.  		 			D E Scott-Drechsel 		,  		 			S Rugonyi 		,  		 			D L Marks 		,  		 			K L Thornburg 		,  		 			M T Hinds 		.  	 	 		\textit{Diabetes}  		2013 Jan. 62  (1)  p. .  	 
\bibitem[Cai et al. (2002)]{b8}\label{b8} 	 		\textit{Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway Diabetes},  		 			L Cai 		,  		 			W Li 		,  		 			G Wang 		,  		 			L Guo 		,  		 			Y Jiang 		,  		 			Y J Kang 		.  		2002 Jun. 51 p. .  	 
\bibitem[Pinter et al. (2001)]{b33}\label{b33} 	 		‘Hyperglycemiainduced vasculopathy in the murine conceptus is mediated via reductions of VEGF-A expression and VEGF receptor activation’.  		 			E Pinter 		,  		 			J Haigh 		,  		 			A Nagy 		,  		 			J A Madri 		.  	 	 		\textit{Am J Pathol}  		2001 Apr. 158  (4)  p. .  	 
\bibitem[Torchinsky et al. (1997)]{b53}\label{b53} 	 		\textit{In vivo evidence for the existence of a threshold for hyperglycemia-induced major fetal malformations: relevance to the etiology of diabetic teratogenesis},  		 			A Torchinsky 		,  		 			V Toder 		,  		 			H Carp 		,  		 			H Orenstein 		,  		 			A Fein 		.  		1997 Mar. 3 p. .  	 
\bibitem[Eriksson et al. (1982)]{b13}\label{b13} 	 		\textit{Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy Diabetes},  		 			U Eriksson 		,  		 			E Dahlström 		,  		 			K S Larsson 		,  		 			C Hellerström 		.  		1982 Jan. 31 p. .  	 
\bibitem[Wu (1996)]{b62}\label{b62} 	 		\textit{Infant of diabetic mother: a continuing challenge for perinatal-neonatal medicine Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi},  		 			P Y Wu 		.  		1996 Sep-Oct. 37 p. .  	 
\bibitem[Wentzel and Eriksson (1996)]{b58}\label{b58} 	 		‘Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats’.  		 			P Wentzel 		,  		 			U J Eriksson 		.  	 	 		\textit{Eur J Endocrinol}  		1996 Apr. 134  (4)  p. .  	 
\bibitem[Fukuda et al. ()]{b21}\label{b21} 	 		‘Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis’.  		 			R Fukuda 		,  		 			A Aharonov 		,  		 			Y T Ong 		,  		 			O A Stone 		,  		 			M El-Brolosy 		,  		 			H M Maischein 		,  		 			M Potente 		,  		 			E Tzahor 		,  		 			National Institute 		,  		 			Child 		,  		 			Development 		,  		 			Early 		,  		 			Study Group 		.  	 	 		\textit{N Engl J Med}  		1988. 318 p. .  	 
\bibitem[Sule et al. (2006)]{b50}\label{b50} 	 		‘Leow MK Potentially fatal paracetamol overdose and successful treatment with 3 days of intravenous Nacetylcysteine regime--a case report’.  		 			A A Sule 		,  		 			D Y Tai 		,  		 			C C Tze 		,  		 			B Deepa 		.  	 	 		\textit{Ann Acad Med Singapore}  		2006 Feb. 35  (2)  p. .  	 
\bibitem[Neto et al. ()]{b28}\label{b28} 	 		‘Long-term acetaminophen (paracetamol) treatment causes liver and kidney ultra-structural changes during rat pregnancy’.  		 			J A Neto 		,  		 			R M Oliveira-Filho 		,  		 			M J Simões 		,  		 			J M SoaresJr 		,  		 			L KulayJr 		.  	 	 		\textit{Clin Exp Obstet Gynecol}  		2004. 31  (3)  p. .  	 
\bibitem[Shi et al. (2017)]{b46}\label{b46} 	 		‘Maternal exosomes in diabetes contribute to the cardiac development deficiency’.  		 			R Shi 		,  		 			L Zhao 		,  		 			W Cai 		,  		 			M Wei 		,  		 			X Zhou 		,  		 			G Yang 		,  		 			L Yuan 		.  	 	 		\textit{Biochem Biophys Res Commun}  		2017 Jan 29. 483  (1)  p. .  	 
\bibitem[Mills et al. (2010)]{b22}\label{b22} 	 		‘Maternal obesity and congenital heart defects: a population-based study’.  		 			J L Mills 		,  		 			J Troendle 		,  		 			M R Conley 		,  		 			T Carter 		,  		 			C M Druschel 		.  	 	 		\textit{Am J Clin Nutr}  		2010 Jun. 91  (6)  p. .  	 
\bibitem[Baker et al. (1981)]{b3}\label{b3} 	 		\textit{Meticulous control of diabetes during organogenesis prevents congenital lumbosacral defects in rats Diabetes},  		 			L Baker 		,  		 			J M Egler 		,  		 			S H Klein 		,  		 			A S Goldman 		.  		1981 Nov. 30 p. .  	 
\bibitem[Frustaci et al. (2000)]{b19}\label{b19} 	 		\textit{Myocardial cell death in human diabetes Circ Res},  		 			A Frustaci 		,  		 			J Kajstura 		,  		 			C Chimenti 		,  		 			I Jakoniuk 		,  		 			A Leri 		,  		 			A Maseri 		,  		 			B Nadal-Ginard 		,  		 			P Anversa 		.  		2000 Dec 8. 87 p. .  	 
\bibitem[Moazzen et al. (2014)]{b25}\label{b25} 	 		\textit{N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes Cardiovasc Diabetol},  		 			H Moazzen 		,  		 			X Lu 		,  		 			N L Ma 		,  		 			T J Velenosi 		,  		 			B L Urquhart 		,  		 			L J Wisse 		,  		 			A C Groot 		,  		 			Q Feng 		.  		2014 Feb 18. 13 p. 46.  	 
\bibitem[Trocino et al. (1995)]{b54}\label{b54} 	 		‘Nagataki S Significance of glutathione depletion and oxidative stress in early embryogenesis in glucoseinduced rat embryo culture’.  		 			R A Trocino 		,  		 			S Akazawa 		,  		 			M Ishibashi 		,  		 			K Matsumoto 		,  		 			H Matsuo 		,  		 			H Yamamoto 		,  		 			S Goto 		,  		 			Y Urata 		,  		 			T Kondo 		.  	 	 		\textit{Diabetes}  		1995 Aug. 44  (8)  p. .  	 
\bibitem[Andersen et al. (2014)]{b2}\label{b2} 	 		\textit{Of mice and men: molecular genetics of congenital heart disease Cell Mol Life Sci},  		 			T A Andersen 		,  		 			Troelsen Kde 		,  		 			L Larsen 		,  		 			LA 		.  		2014 Apr. 71 p. .  	 
\bibitem[Bessems and Vermeulen (2001)]{b6}\label{b6} 	 		‘Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches’.  		 			J G Bessems 		,  		 			N P Vermeulen 		.  	 	 		\textit{Crit Rev Toxicol}  		2001 Jan. 31  (1)  p. .  	 
\bibitem[Paolisso et al. ()]{b31}\label{b31} 	 		‘Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients’.  		 			G Paolisso 		,  		 			D `´amore 		,  		 			A Giugliano 		,  		 			D Ceriello 		,  		 			A Varricchio 		,  		 			M Onofrio 		,  		 			F 		.  	 	 		\textit{Am J Clin Nutr}  		1993. 57 p. .  	 
\bibitem[Roman ()]{b39}\label{b39} 	 		‘Preconception care for women with preexisting type 2 diabetes’.  		 			M A Roman 		.  	 	 		\textit{Clin Diabetes}  		2011. 29 p. .  	 
\bibitem[Bauer and Kriebel ()]{b4}\label{b4} 	 		\textit{Prenatal and perinatal analgesic exposure and autism: an ecological link Environ Health},  		 			A Z Bauer 		,  		 			D Kriebel 		.  		 \xref{http://dx.doi.org/10.1186/1476-069X-12-41}{10.1186/1476-069X-12-41}.  		2013 May 9. 12 p. 41.  	 
\bibitem[Burdan et al. ()]{b7}\label{b7} 	 		‘Prenatal tolerability of acetaminophen and other over-thecounter non-selective cyclooxygenase inhibitors’.  		 			F Burdan 		,  		 			E Staros?awska 		,  		 			J Szumi?o 		.  	 	 		\textit{Pharmacol Rep}  		2012. 64  (3)  p. .  	 
\bibitem[Ryan ()]{b41}\label{b41} 	 		‘Prevention and Treatment of Diabetes and Its Complications Medical Clinics of’.  		 			E A Ryan 		.  	 	 		\textit{North America}  		1998. 82 p. .  	 
\bibitem[Reece and Wu (1997)]{b34}\label{b34} 	 		‘Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant’.  		 			E A Reece 		,  		 			Y K Wu 		.  	 	 		\textit{Am J Obstet Gynecol}  		1997 Apr. 176  (4)  p. .  	 
\bibitem[Vaziri et al. ()]{b57}\label{b57} 	 		‘Rad B Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats’.  		 			N D Vaziri 		,  		 			X Q Wang 		,  		 			F Oveisi 		.  	 	 		\textit{Hypertension}  		2000. 36 p. .  	 
\bibitem[Nielsen et al. (2005)]{b29}\label{b29} 	 		‘Risk of specific congenital abnormalities in offspring of women with diabetes’.  		 			G L Nielsen 		,  		 			B Nørgard 		,  		 			E Puho 		,  		 			K J Rothman 		,  		 			H T Sørensen 		,  		 			A E Czeizel 		.  	 	 		\textit{Diabet Med}  		2005 Jun. 22  (6)  p. .  	 
\bibitem[Salomon and Rice ()]{b43}\label{b43} 	 		‘Role of Exosomes in Placental Homeostasis and Pregnancy Disorders’.  		 			C Salomon 		,  		 			G E Rice 		.  	 	 		\textit{Prog Mol Biol Transl Sci}  		2017. 145 p. .  	 
\bibitem[Seo et al. (2004)]{b44}\label{b44} 	 		\textit{Role of glutathione in the adaptive tolerance to H2O2. Free Radic Biol Med},  		 			Y J Seo 		,  		 			J W Lee 		,  		 			E H Lee 		,  		 			H K Lee 		,  		 			H W Kim 		,  		 			Y H Kim 		.  		2004 Oct 15. 37 p. .  	 
\bibitem[Sudano et al. ()]{b49}\label{b49} 	 		\textit{Ruschitzka F Acetaminophen Increases Blood Pressure in Ambulatory Patients With Coronary Artery Disease Circulation},  		 			I Sudano 		,  		 			A J Flammer 		,  		 			D Periat 		,  		 			F Enseleit 		,  		 			M Hermman 		,  		 			M Wolfrum 		,  		 			A Hirt 		,  		 			P Kaiser 		,  		 			D Hurlimman 		,  		 			M Neidhart 		,  		 			S Gay 		,  		 			J Holzmeister 		,  		 			J Nussberger 		,  		 			P Mocharla 		,  		 			U Landmesser 		,  		 			S R Haile 		,  		 			R Corti 		,  		 			P M Vanhoutte 		,  		 			T F Luscher 		,  		 			G Noil 		.  		2010. 122 p. .  	 
\bibitem[Mitchell et al. (2015)]{b24}\label{b24} 	 		‘Salomon C Placental exosomes in normal and complicated pregnancy’.  		 			M D Mitchell 		,  		 			H N Peiris 		,  		 			M Kobayashi 		,  		 			Y Q Koh 		,  		 			G Duncombe 		,  		 			S E Illanes 		,  		 			G E Rice 		.  	 	 		\textit{Am J Obstet Gynecol}  		2015 Oct. 213  (4)  p. .  	 	 (Suppl) 
\bibitem[Sakamaki et al. (1999)]{b42}\label{b42} 	 		‘Significance of glutathionedependent antioxidant system in diabetes-induced embryonic malformations’.  		 			H Sakamaki 		,  		 			S Akazawa 		,  		 			M Ishibashi 		,  		 			K Izumino 		,  		 			H Takino 		,  		 			H Yamasaki 		,  		 			Y Yamaguchi 		,  		 			S Goto 		,  		 			Y Urata 		,  		 			T Kondo 		,  		 			S Nagataki 		.  	 	 		\textit{Diabetes}  		1999 May. 48  (5)  p. .  	 
\bibitem[Allen et al. (2007)]{b1}\label{b1} 	 		\textit{Society of Obstetricians and Gynecologists of Canada Teratogenicity associated with preexisting and gestational diabetes J Obstet Gynaecol Can},  		 			V M Allen 		,  		 			B A Armson 		,  		 			R D Wilson 		,  		 			V M Allen 		,  		 			C Blight 		,  		 			A Gagnon 		,  		 			J A Johnson 		,  		 			S Langlois 		,  		 			A Summers 		,  		 			P Wyatt 		,  		 			D Farine 		,  		 			B A Armson 		,  		 			J Crane 		,  		 			M F Delisle 		,  		 			L Keenan-Lindsay 		,  		 			V Morin 		,  		 			C E Schneider 		,  		 			J Van Aerde 		.  		2007 Nov. 29 p. .  	 
\bibitem[Beck et al. (2001)]{b5}\label{b5} 	 		‘Spatial glutathione and cysteine distribution and chemical modulation in the early organogenesisstage rat conceptus in utero’.  		 			M J Beck 		,  		 			C Mclellan 		,  		 			R L Lightle 		,  		 			M A Philbert 		,  		 			C Harris 		.  	 	 		\textit{Toxicol Sci}  		2001 Jul. 62  (1)  p. .  	 
\bibitem[Navarrete et al. (1970)]{b27}\label{b27} 	 		‘Subsequent diabetes in mothers delivered of a malformed infant’.  		 			V N Navarrete 		,  		 			C E Rojas 		,  		 			C R Alger 		,  		 			H E Paniagua 		.  	 	 		\textit{Lancet}  		1970 Nov 14.  	 
\bibitem[Wentzel et al. (1997)]{b59}\label{b59} 	 		\textit{Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and Nacetylcysteine in rat embryo culture Diabetologia},  		 			P Wentzel 		,  		 			L Thunberg 		,  		 			U J Eriksson 		.  		1997 Jan. 40 p. .  	 
\bibitem[Zhong et al. (2018)]{b65}\label{b65} 	 		‘The current status and future of cardiac stem/progenitor cell therapy for congenital heart defects from diabetic pregnancy’.  		 			J Zhong 		,  		 			S Wang 		,  		 			W B Shen 		,  		 			S Kaushal 		,  		 			P Yang 		.  	 	 		\textit{Pediatr Res}  		2018 Jan. 83  (1-2)  p. .  	 
\bibitem[Rice et al. (2015)]{b37}\label{b37} 	 		‘The Effect of Glucose on the Release and Bioactivity of Exosomes From First Trimester Trophoblast Cells’.  		 			G E Rice 		,  		 			K Scholz-Romero 		,  		 			E Sweeney 		,  		 			H Peiris 		,  		 			M Kobayashi 		,  		 			G Duncombe 		,  		 			M D Mitchell 		,  		 			C Salomon 		.  	 	 		\textit{J Clin Endocrinol Metab}  		2015 Oct. 100  (10)  p. .  	 
\bibitem[Fuhrmann et al. (1984)]{b20}\label{b20} 	 		‘The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers’.  		 			K Fuhrmann 		,  		 			H Reiher 		,  		 			K Semmler 		,  		 			E Glöckner 		.  	 	 		\textit{Exp Clin Endocrinol}  		1984 Apr. 83  (2)  p. .  	 
\bibitem[Todorova et al. ()]{b52}\label{b52} 	 		‘The frequency of mild and severe fetal malformations in diabetic women with high values of glycosilated hemoglobin in early pregnancy’.  		 			K Todorova 		,  		 			V Mazne?kova 		,  		 			S Ivanov 		,  		 			M Genova 		.  	 	 		\textit{Akush Ginekol (Sofiia)}  		2005. 44  (3)  p. .  	 
\bibitem[Zhou and Lu (2013)]{b66}\label{b66} 	 		‘The role of oxidative stress in high glucose-induced apoptosis in neonatal rat cardiomyocytes’.  		 			X Zhou 		,  		 			X Lu 		.  	 	 		\textit{Exp Biol Med (Maywood)}  		2013 Aug 1. 238  (8)  p. .  	 
\bibitem[Farquhar et al. (2010)]{b16}\label{b16} 	 		‘The role of paracetamol in the pathogenesis of asthma’.  		 			H Farquhar 		,  		 			A Stewart 		,  		 			E Mitchell 		,  		 			J Crane 		,  		 			S Eyers 		,  		 			M Weatherall 		,  		 			R Beasley 		.  	 	 		\textit{Clin Exp Allergy}  		2010 Jan. 40  (1)  p. .  	 
\bibitem[Eriksson and Wentzel (2016)]{b15}\label{b15} 	 		‘The status of diabetic embryopathy’.  		 			U J Eriksson 		,  		 			P Wentzel 		.  	 	 		\textit{Ups J Med Sci}  		2016 May. 121  (2)  p. .  	 
\bibitem[Zabihi and Loeken (2010)]{b64}\label{b64} 	 		‘Understanding diabetic teratogenesis: where are we now and where are we going?’.  		 			S1 Zabihi 		,  		 			M R Loeken 		.  	 	 		\textit{Birth Defects Res A Clin Mol Teratol}  		2010 Oct. 88  (10)  p. .  	 
\bibitem[Simán and Eriksson (1997)]{b47}\label{b47} 	 		\textit{Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats Diabetes},  		 			C M Simán 		,  		 			U J Eriksson 		.  		1997 Jun. 46 p. .  	 
\bibitem[Pinter et al. (1986)]{b32}\label{b32} 	 		\textit{Yolk sac failure in embryopathy due to hyperglycemia: ultrastructural analysis of yolk sac differentiation associated with embryopathy in rat conceptuses under hyperglycemic conditions Teratology},  		 			E Pinter 		,  		 			E A Reece 		,  		 			C Z Leranth 		,  		 			M K Sanyal 		,  		 			J C Hobbins 		,  		 			M J Mahoney 		,  		 			F Naftolin 		.  		1986 Feb. 33 p. .  	 
\end{bibitemlist}
 			 		 	 
\end{document}
